Profile
Based on the SEC filing dated 2026-01-23, Lily Cheung serves as the Chief Human Resource Officer of Pliant Therapeutics, Inc. She is responsible for leading human resources strategy, talent acquisition, and organizational development to support the company's clinical development efforts for fibrosis therapies, including bexotegrast (PLN-74809).
| Role | Chief Human Resource Officer |
|---|
| Notability | 40/100 |
|---|
Board memberships
- Pliant Therapeutics, Inc.
Awards & honors
- Led global human resources strategy and talent management for a clinical-stage biopharmaceutical company.
- Oversaw HR operations, compliance, and organizational development during periods of rapid growth.
- Built HR programs to support bexotegrast development and regulatory milestone achievements.
Frequently Asked Questions
Who is Cheung Lily?
Based on the SEC filing dated 2026-01-23, Lily Cheung serves as the Chief Human Resource Officer of Pliant Therapeutics, Inc. She is responsible for leading human resources strategy, talent acquisition, and organizational development to support the company's clinical development efforts for fibrosis therapies, including bexotegrast (PLN-74809).…
How many SEC Form 4 filings has Cheung Lily submitted recently?
1 primary Form 4 filings in the last 90 days, covering 1 company.
Has Cheung Lily been buying or selling stock?
Recorded transactions: 0 open-market purchases () and 1 open-market sales ($10K) across all tracked filings.
Where can I see all of Cheung Lily's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.